Miscarriages could be prevented with diabetes drug

A diabetes drug could also be used to prevent miscarriage by targeting the lining of the womb, according to a clinical trial led by Tommy’s National Centre for Miscarriage Research at the University of Warwick. Recurrent miscarriage is defined as the loss of three or more consecutive pregnancies, with each additional miscarriage decreasing the likelihood of a successful pregnancy. Previous research by the Warwick team found that women who experience recurrent miscarriages do not have enough stem cells in the lining of their wombs. Many cells in the womb are renewed often, for example after a woman’s period when the lining of the womb regrows. Stem cells are essential in this process.